Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.12 trillion and total revenue of $109.95 billion.
Market Cap
1.12T
Revenue
109.95B
Profits
-41.25B
PE Ratio
n/a
Profit Margin
-37.52%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 126.54B | 8.08% | 2,483,621 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.43B | -0.96% | 255,860 | 14.34B |
| 3 | ARGX | argenx SE | 44.74B | 0.35% | 234,686 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.77B | -0.33% | 569,628 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.93B | 1.16% | 99,202 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.10B | 0.80% | 469,873 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.60B | 0.61% | 1,246,940 | 2.38B |
| 8 | MRNA | Moderna, Inc. | 21.65B | -1.63% | 5,518,624 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 21.28B | 0.71% | 3,196,657 | 13.31M |
| 10 | BNTX | BioNTech SE | 21.06B | -17.85% | 11,119,209 | 3.37B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.80B | 0.12% | 1,523,692 | - |
| 12 | INCY | Incyte Corporation | 19.18B | -0.72% | 604,403 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.45B | 3.18% | 1,457,463 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.81B | 0.56% | 223,885 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.38B | 13.03% | 4,671,099 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.69B | 4.07% | 2,083,274 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.61B | 1.27% | 2,178,331 | 943.71M |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.77B | 0.56% | 722,259 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.50B | 0.76% | 534,431 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.76B | -2.24% | 1,442,196 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.99B | 0.49% | 127,900 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 9.00B | 5.33% | 431,184 | 6.23M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | 0.42% | 293,144 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.52B | 1.29% | 281,822 | 638.50M |
| 25 | TECH | Bio-Techne Corporation | 8.40B | -2.19% | 1,587,158 | 1.22B |
| 26 | PCVX | Vaxcyte, Inc. | 8.36B | -2.02% | 505,514 | - |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.35B | -1.76% | 1,604,811 | 1.09B |
| 28 | IBRX | ImmunityBio, Inc. | 8.14B | -6.27% | 21,082,994 | 113.29M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.02B | -0.22% | 589,489 | 1.40B |
| 30 | NUVL | Nuvalent, Inc. | 8.02B | -0.28% | 245,536 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.78B | 1.20% | 1,147,546 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.59B | 0.33% | 155,428 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.96B | 0.24% | 215,463 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.87B | -2.56% | 141,543 | - |
| 35 | ACLX | Arcellx, Inc. | 6.71B | -0.11% | 2,241,761 | 22.29M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.39B | 0.65% | 296,786 | 189.76M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.20B | 0.57% | 651,390 | 46.02M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.93B | -0.49% | 613,647 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.64B | -0.37% | 713,802 | 1.73B |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 5.44B | 1.52% | 458,621 | 521.31M |
| 41 | CELC | Celcuity Inc. | 5.42B | 3.31% | 435,485 | - |
| 42 | CGON | CG Oncology, Inc. | 5.27B | 1.83% | 1,007,084 | 4.04M |
| 43 | IMVT | Immunovant, Inc. | 5.26B | -2.20% | 767,499 | - |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.24B | 1.60% | 393,998 | - |
| 45 | CAI | Caris Life Sciences, Inc. | 5.23B | -2.63% | 1,179,728 | 812.03M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.20B | 2.40% | 1,471,404 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.06B | -3.10% | 2,647,364 | 7.50M |
| 48 | TERN | Terns Pharmaceuticals, Inc. | 4.93B | 2.37% | 1,599,315 | - |
| 49 | CRSP | CRISPR Therapeutics AG | 4.91B | -12.98% | 5,546,918 | 3.51M |
| 50 | ERAS | Erasca, Inc. | 4.76B | -2.35% | 3,549,610 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.51B | -0.10% | 2,625,750 | 634.21M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.30B | -0.24% | 640,875 | 616.29M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.22B | 1.74% | 207,933 | 268.09M |
| 54 | GPCR | Structure Therapeutics Inc. | 4.22B | 5.49% | 701,857 | - |
| 55 | VKTX | Viking Therapeutics, Inc. | 4.02B | 3.48% | 2,388,832 | - |
| 56 | CNTA | Centessa Pharmaceuticals plc | 4.00B | 4.87% | 1,173,228 | 15.00M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.93B | -1.86% | 748,302 | 7.70M |
| 58 | ADMA | ADMA Biologics, Inc. | 3.81B | 1.17% | 1,250,139 | 510.17M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.81B | -1.06% | 692,591 | 1.07B |
| 60 | DNTH | Dianthus Therapeutics, Inc. | 3.80B | 7.75% | 1,647,542 | 2.04M |
| 61 | LEGN | Legend Biotech Corporation | 3.59B | 1.67% | 1,267,876 | 1.03B |
| 62 | CORT | Corcept Therapeutics Incorporated | 3.58B | -0.88% | 639,585 | 761.41M |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.56B | 0.65% | 718,622 | 22.50M |
| 64 | ALMS | Alumis Inc. | 3.49B | 4.43% | 754,892 | 22.12M |
| 65 | DNLI | Denali Therapeutics Inc. | 3.42B | 1.22% | 1,111,556 | - |
| 66 | SYRE | Spyre Therapeutics, Inc. | 3.26B | 1.17% | 426,999 | - |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.24B | 10.97% | 4,112,041 | - |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.16B | 2.72% | 476,337 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.10B | -2.35% | 374,202 | 451.36M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.09B | 5.38% | 916,868 | 247.00M |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -0.89% | 587,835 | 376.07M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -0.97% | 442,726 | 218.71M |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.03B | 0.24% | 969,519 | 588.99M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 3.00B | -0.91% | 706,465 | 70.85M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.93B | 5.47% | 1,543,031 | - |
| 76 | TLX | Telix Pharmaceuticals Limited | 2.66B | 5.47% | 267,108 | 803.79M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.61B | -2.38% | 544,902 | 490.73M |
| 78 | WVE | Wave Life Sciences Ltd. | 2.59B | 3.46% | 1,269,756 | 42.73M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.59B | -5.65% | 819,326 | 139.74M |
| 80 | APLS | Apellis Pharmaceuticals, Inc. | 2.53B | -1.10% | 610,622 | 1.00B |
| 81 | IRON | Disc Medicine, Inc. | 2.49B | 1.70% | 253,506 | - |
| 82 | IMNM | Immunome, Inc. | 2.45B | 1.64% | 530,933 | 6.94M |
| 83 | MAZE | Maze Therapeutics, Inc. | 2.41B | 11.36% | 786,916 | 2.50M |
| 84 | TNGX | Tango Therapeutics, Inc. | 2.38B | 1.22% | 1,426,811 | 62.38M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.28B | 5.95% | 3,082,696 | - |
| 86 | ADPT | Adaptive Biotechnologies Corporation | 2.25B | -2.27% | 1,214,302 | 276.98M |
| 87 | AAPG | Ascentage Pharma Group International | 2.21B | 2.36% | 2,666 | 54.52M |
| 88 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | -0.19% | 4,530,264 | 158.18M |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.19B | 0.62% | 604,484 | 673.00M |
| 90 | STOK | Stoke Therapeutics, Inc. | 2.19B | 0.18% | 860,795 | 205.63M |
| 91 | ZLAB | Zai Lab Limited | 2.18B | 1.52% | 193,465 | 460.16M |
| 92 | GLPG | Galapagos NV | 2.15B | 0.67% | 60,923 | 1.31B |
| 93 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | 2.01% | 1,308,560 | 172.35M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.14B | -1.01% | 3,327,878 | 51.95M |
| 95 | IOVA | Iovance Biotherapeutics, Inc. | 2.13B | -4.44% | 13,383,506 | 263.50M |
| 96 | SLNO | Soleno Therapeutics, Inc. | 2.10B | 2.09% | 628,432 | 190.41M |
| 97 | CLDX | Celldex Therapeutics, Inc. | 2.04B | -0.13% | 744,639 | 1.55M |
| 98 | MESO | Mesoblast Limited | 2.01B | 1.56% | 163,905 | 65.38M |
| 99 | NKTR | Nektar Therapeutics | 1.99B | 2.95% | 364,160 | 62.60M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | 2.64% | 537,447 | 283.06M |
| 101 | MANE | Veradermics, Incorporated | 1.92B | 0.14% | 207,525 | - |
| 102 | RLAY | Relay Therapeutics, Inc. | 1.91B | 5.62% | 4,774,324 | 15.36M |
| 103 | PVLA | Palvella Therapeutics, Inc. | 1.91B | 3.98% | 186,026 | - |
| 104 | DFTX | Definium Therapeutics, Inc. | 1.90B | 3.76% | 1,766,725 | - |
| 105 | NBTX | Nanobiotix S.A. | 1.88B | -3.36% | 94,336 | 11.93M |
| 106 | TYRA | Tyra Biosciences, Inc. | 1.87B | 3.05% | 556,173 | - |
| 107 | ZYME | Zymeworks Inc. | 1.87B | 4.66% | 1,334,056 | 105.97M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.84B | -0.79% | 1,921,305 | 2.20B |
| 109 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | -2.56% | 8,080,132 | 74.68M |
| 110 | ELVN | Enliven Therapeutics, Inc. | 1.80B | 1.50% | 692,041 | - |
| 111 | ANAB | AnaptysBio, Inc. | 1.77B | 3.02% | 352,816 | 234.60M |
| 112 | CAPR | Capricor Therapeutics, Inc. | 1.73B | 9.50% | 4,257,434 | 11.13M |
| 113 | NVAX | Novavax, Inc. | 1.71B | -0.43% | 2,685,078 | 1.12B |
| 114 | SION | Sionna Therapeutics, Inc. | 1.71B | 1.33% | 181,349 | - |
| 115 | VCEL | Vericel Corporation | 1.71B | -1.47% | 354,635 | 276.26M |
| 116 | IMCR | Immunocore Holdings plc | 1.70B | 0.30% | 85,399 | 400.02M |
| 117 | OCS | Oculis Holding AG | 1.69B | 4.58% | 1,829,623 | 1.51M |
| 118 | PHVS | Pharvaris N.V. | 1.69B | -2.04% | 118,830 | - |
| 119 | INVA | Innoviva, Inc. | 1.67B | 1.12% | 340,665 | 411.33M |
| 120 | HRMY | Harmony Biosciences Holdings, Inc. | 1.66B | 0.32% | 299,445 | 868.45M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.65B | 3.61% | 657,251 | 83.98M |
| 122 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | -1.75% | 277,022 | 54.03M |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.64B | 0.68% | 229,389 | - |
| 124 | NUVB | Nuvation Bio Inc. | 1.61B | -0.74% | 2,119,090 | 62.90M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -3.38% | 1,991,248 | 67.67M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.58B | 0.61% | 2,082,043 | 68.56M |
| 127 | KOD | Kodiak Sciences Inc. | 1.55B | -2.84% | 318,435 | - |
| 128 | GENB | Generate Biomedicines, Inc. | 1.55B | -0.16% | 674,538 | 31.89M |
| 129 | BHVN | Biohaven Ltd. | 1.53B | -0.10% | 2,914,322 | - |
| 130 | ATAI | AtaiBeckley Inc. | 1.52B | 7.46% | 8,703,491 | 3.02M |
| 131 | TRVI | Trevi Therapeutics, Inc. | 1.51B | 0.85% | 1,209,616 | - |
| 132 | ARDX | Ardelyx, Inc. | 1.50B | -0.97% | 1,968,987 | 407.32M |
| 133 | RAPP | Rapport Therapeutics, Inc. | 1.43B | -2.10% | 393,777 | - |
| 134 | IMTX | Immatics N.V. | 1.42B | 6.00% | 718,622 | 56.67M |
| 135 | CRVS | Corvus Pharmaceuticals, Inc. | 1.40B | 5.41% | 1,047,668 | - |
| 136 | SVRA | Savara Inc. | 1.40B | 4.42% | 655,423 | - |
| 137 | GLUE | Monte Rosa Therapeutics, Inc. | 1.39B | -0.85% | 406,514 | 181.54M |
| 138 | MBX | MBX Biosciences, Inc. | 1.37B | 4.33% | 430,634 | - |
| 139 | ZBIO | Zenas BioPharma, Inc. | 1.37B | -2.72% | 194,077 | 15.00M |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.32B | 0.60% | 567,284 | - |
| 141 | BCAX | Bicara Therapeutics Inc. | 1.30B | 1.47% | 671,265 | - |
| 142 | DBVT | DBV Technologies S.A. | 1.30B | 0.44% | 232,923 | 5.50M |
| 143 | EYPT | EyePoint, Inc. | 1.29B | -1.08% | 802,034 | 31.37M |
| 144 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | 8.41% | 1,227,220 | - |
| 145 | OLMA | Olema Pharmaceuticals, Inc. | 1.25B | -0.31% | 2,993,950 | - |
| 146 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | -0.65% | 866,771 | 6.31M |
| 147 | SEPN | Septerna, Inc. | 1.25B | -4.51% | 161,655 | 45.95M |
| 148 | PGEN | Precigen, Inc. | 1.23B | -0.85% | 1,509,787 | 6.31M |
| 149 | IVA | Inventiva S.A. | 1.18B | 2.35% | 325,758 | 19.93M |
| 150 | QURE | uniQure N.V. | 1.15B | 2.56% | 2,800,972 | 16.10M |
| 151 | AVBP | ArriVent BioPharma, Inc. | 1.12B | 1.77% | 906,062 | - |
| 152 | PHAR | Pharming Group N.V. | 1.11B | 1.09% | 30,858 | 362.27M |
| 153 | ABCL | AbCellera Biologics Inc. | 1.08B | 0.85% | 1,696,551 | 75.13M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.06B | 0.97% | 98,158 | 1.40M |
| 155 | GERN | Geron Corporation | 1.02B | -1.54% | 18,078,820 | 183.88M |
| 156 | AKTS | Aktis Oncology, Inc. | 1.01B | 0.42% | 165,646 | 5.56M |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.00B | 2.95% | 1,011,542 | 850.00K |
| 158 | XERS | Xeris Biopharma Holdings, Inc. | 988.03M | 2.32% | 1,343,982 | 291.85M |
| 159 | SLS | SELLAS Life Sciences Group, Inc. | 984.23M | -3.02% | 5,677,271 | - |
| 160 | GHRS | GH Research PLC | 980.06M | -1.13% | 398,319 | - |
| 161 | URGN | UroGen Pharma Ltd. | 947.84M | -2.21% | 333,783 | 109.79M |
| 162 | VALN | Valneva SE | 942.29M | 7.62% | 26,000 | 211.09M |
| 163 | KALV | KalVista Pharmaceuticals, Inc. | 938.64M | 7.34% | 1,072,613 | 1.43M |
| 164 | ABUS | Arbutus Biopharma Corporation | 907.77M | - | 1,738,813 | 14.61M |
| 165 | ANNX | Annexon, Inc. | 901.79M | 8.23% | 1,524,737 | - |
| 166 | SGP | SpyGlass Pharma, Inc. | 899.57M | -0.44% | 268,477 | - |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 894.59M | -4.13% | 1,401,451 | 185.74M |
| 168 | ARVN | Arvinas, Inc. | 888.42M | 3.89% | 474,460 | 262.60M |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 888.06M | 1.44% | 384,197 | 175.11M |
| 170 | SPRY | ARS Pharmaceuticals, Inc. | 885.73M | -1.44% | 822,928 | 84.28M |
| 171 | EVMN | Evommune, Inc. | 885.33M | -0.12% | 281,394 | 13.00M |
| 172 | XNCR | Xencor, Inc. | 880.06M | 1.10% | 561,128 | 125.58M |
| 173 | SANA | Sana Biotechnology, Inc. | 875.32M | -1.50% | 1,723,395 | - |
| 174 | CGEM | Cullinan Therapeutics, Inc. | 874.33M | -3.33% | 704,937 | - |
| 175 | JANX | Janux Therapeutics, Inc. | 854.68M | 0.50% | 434,249 | 10.00M |
| 176 | MPLT | MapLight Therapeutics, Inc. | 853.19M | -1.21% | 110,552 | - |
| 177 | FTRE | Fortrea Holdings Inc. | 849.92M | -7.53% | 2,308,250 | 2.72B |
| 178 | CTMX | CytomX Therapeutics, Inc. | 835.32M | -1.99% | 1,580,757 | 113.63M |
| 179 | OMER | Omeros Corporation | 830.95M | 3.81% | 621,859 | - |
| 180 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 818.74M | -0.78% | 121,964 | - |
| 181 | KURA | Kura Oncology, Inc. | 817.05M | -1.49% | 1,127,557 | 67.48M |
| 182 | MNKD | MannKind Corporation | 797.98M | -3.36% | 3,072,113 | 348.97M |
| 183 | DRUG | Bright Minds Biosciences Inc. | 793.06M | -0.51% | 93,362 | - |
| 184 | EIKN | Eikon Therapeutics, Inc. | 776.29M | -3.55% | 109,601 | - |
| 185 | PROK | ProKidney Corp. | 752.09M | 4.60% | 709,535 | 744.00K |
| 186 | GYRE | Gyre Therapeutics, Inc. | 744.39M | 0.37% | 92,333 | 107.27M |
| 187 | JBIO | Jade Biosciences, Inc. | 723.47M | 1.66% | 879,633 | - |
| 188 | PRME | Prime Medicine, Inc. | 718.06M | -1.34% | 1,417,044 | 4.63M |
| 189 | TBPH | Theravance Biopharma, Inc. | 707.39M | -0.29% | 336,192 | 80.33M |
| 190 | LXRX | Lexicon Pharmaceuticals, Inc. | 690.60M | -2.98% | 2,712,222 | 49.80M |
| 191 | REPL | Replimune Group, Inc. | 682.88M | -4.17% | 1,256,666 | - |
| 192 | AGMB | AgomAb Therapeutics NV | 682.31M | -2.98% | 141,734 | - |
| 193 | MDXG | MiMedx Group, Inc. | 675.98M | 0.89% | 512,784 | 418.63M |
| 194 | VOR | Vor Biopharma Inc. | 668.88M | 4.20% | 677,350 | - |
| 195 | ZURA | Zura Bio Limited | 661.28M | -0.99% | 494,430 | - |
| 196 | ANRO | Alto Neuroscience, Inc. | 653.79M | -4.30% | 138,008 | - |
| 197 | ZVRA | Zevra Therapeutics, Inc. | 652.87M | 21.93% | 8,495,750 | 106.47M |
| 198 | TECX | Tectonic Therapeutic, Inc. | 630.14M | -1.29% | 249,835 | - |
| 199 | SLDB | Solid Biosciences Inc. | 626.40M | 0.25% | 1,996,702 | - |
| 200 | MGTX | MeiraGTx Holdings plc | 616.56M | 3.93% | 781,486 | 27.42M |
| 201 | DSGN | Design Therapeutics, Inc. | 613.02M | -4.15% | 140,198 | - |
| 202 | LBRX | LB Pharmaceuticals Inc | 605.66M | -1.64% | 167,502 | - |
| 203 | LRMR | Larimar Therapeutics, Inc. | 599.42M | -2.99% | 1,881,323 | - |
| 204 | ADCT | ADC Therapeutics SA | 593.37M | 13.24% | 1,266,473 | 81.36M |
| 205 | ALLO | Allogene Therapeutics, Inc. | 593.29M | 5.60% | 3,315,901 | 22.00K |
| 206 | DRTS | Alpha Tau Medical Ltd. | 588.32M | 2.83% | 246,169 | - |
| 207 | OCGN | Ocugen, Inc. | 578.74M | 6.33% | 3,781,902 | 4.41M |
| 208 | VNDA | Vanda Pharmaceuticals Inc. | 565.07M | 10.14% | 3,267,713 | 216.11M |
| 209 | VSTM | Verastem, Inc. | 563.90M | 1.90% | 558,969 | 30.91M |
| 210 | NMRA | Neumora Therapeutics, Inc. | 562.50M | 2.80% | 860,404 | - |
| 211 | RCKT | Rocket Pharmaceuticals, Inc. | 561.30M | 1.17% | 3,013,049 | - |
| 212 | YDES | YD Bio Limited | 547.09M | -1.52% | 10,934 | 510.36K |
| 213 | LYEL | Lyell Immunopharma, Inc. | 546.39M | 0.86% | 92,100 | 41.00K |
| 214 | TENX | Tenax Therapeutics, Inc. | 545.67M | 22.05% | 1,638,819 | - |
| 215 | IMMX | Immix Biopharma, Inc. | 542.76M | 1.68% | 651,654 | - |
| 216 | RIGL | Rigel Pharmaceuticals, Inc. | 534.98M | 3.17% | 332,089 | 294.28M |
| 217 | KYTX | Kyverna Therapeutics, Inc. | 531.30M | 10.71% | 803,909 | - |
| 218 | FULC | Fulcrum Therapeutics, Inc. | 530.80M | 0.38% | 793,804 | 80.00M |
| 219 | PRTA | Prothena Corporation plc | 526.76M | -0.25% | 471,138 | 9.68M |
| 220 | CRMD | CorMedix Inc. | 524.89M | 1.22% | 1,267,080 | 311.71M |
| 221 | LXEO | Lexeo Therapeutics, Inc. | 524.78M | -3.36% | 979,146 | - |
| 222 | IVVD | Invivyd, Inc. | 521.39M | -2.38% | 2,796,669 | 53.43M |
| 223 | RGNX | REGENXBIO Inc. | 512.52M | -4.34% | 801,949 | 170.44M |
| 224 | FBRX | Forte Biosciences, Inc. | 511.67M | 2.56% | 189,424 | - |
| 225 | ALT | Altimmune, Inc. | 502.07M | -0.52% | 2,514,494 | 41.00K |
| 226 | CTNM | Contineum Therapeutics, Inc. | 500.30M | -1.03% | 211,340 | - |
| 227 | IPSC | Century Therapeutics, Inc. | 499.42M | -5.44% | 1,329,318 | 113.34M |
| 228 | AVIR | Atea Pharmaceuticals, Inc. | 493.97M | 0.81% | 843,045 | - |
| 229 | ENGN | enGene Holdings Inc. | 485.67M | 2.84% | 2,674,036 | - |
| 230 | RLMD | Relmada Therapeutics, Inc. | 483.27M | -8.09% | 3,785,328 | - |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 471.96M | 3.71% | 159,777 | - |
| 232 | TRDA | Entrada Therapeutics, Inc. | 471.60M | 3.15% | 151,561 | 25.42M |
| 233 | ASMB | Assembly Biosciences, Inc. | 460.75M | - | 62,852 | 37.19M |
| 234 | LCTX | Lineage Cell Therapeutics, Inc. | 450.85M | 2.26% | 1,027,257 | 14.56M |
| 235 | FDMT | 4D Molecular Therapeutics, Inc. | 448.36M | 0.69% | 368,204 | 120.00K |
| 236 | VTVT | vTv Therapeutics Inc. | 447.59M | -1.23% | 96,445 | 17.00K |
| 237 | ACRS | Aclaris Therapeutics, Inc. | 440.17M | 7.67% | 9,533,776 | 7.83M |
| 238 | UPB | Upstream Bio, Inc. | 438.79M | 0.74% | 409,123 | 2.80M |
| 239 | AVXL | Anavex Life Sciences Corp. | 431.85M | -2.71% | 485,382 | - |
| 240 | PEPG | PepGen Inc. | 427.82M | 11.13% | 647,200 | - |
| 241 | ARMP | Armata Pharmaceuticals, Inc. | 427.05M | 1.03% | 43,594 | 5.05M |
| 242 | AUTL | Autolus Therapeutics plc | 426.20M | -1.15% | 1,167,001 | 51.13M |
| 243 | STTK | Shattuck Labs, Inc. | 425.81M | -1.16% | 286,158 | 1.00M |
| 244 | BNTC | Benitec Biopharma Inc. | 424.08M | -1.35% | 177,904 | - |
| 245 | DMAC | DiaMedica Therapeutics Inc. | 423.81M | 1.54% | 139,837 | - |
| 246 | STRO | Sutro Biopharma, Inc. | 419.85M | 2.56% | 131,167 | 105.65M |
| 247 | CBIO | Crescent Biopharma, Inc. | 419.16M | 4.99% | 398,885 | 10.84M |
| 248 | NAGE | Niagen Bioscience, Inc. | 417.29M | 1.76% | 1,413,175 | 129.42M |
| 249 | XFOR | X4 Pharmaceuticals, Inc. | 414.45M | 14.22% | 1,215,381 | 33.98M |
| 250 | IMMP | Immutep Limited | 408.45M | 1.81% | 5 | 5.28M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 400.47M | -0.65% | 37,147 | 66.98M |
| 252 | PRTC | PureTech Health plc | 395.82M | 5.61% | 11,308 | 6.39M |
| 253 | MNPR | Monopar Therapeutics Inc. | 394.81M | 1.74% | 90,194 | - |
| 254 | ABSI | Absci Corporation | 378.94M | 0.40% | 1,524,982 | 2.82M |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 377.12M | 5.67% | 166,424 | - |
| 256 | CADL | Candel Therapeutics, Inc. | 375.76M | - | 1,411,263 | - |
| 257 | LENZ | LENZ Therapeutics, Inc. | 375.48M | -2.44% | 281,267 | 17.50M |
| 258 | NBP | NovaBridge Biosciences | 374.12M | -7.42% | 660,732 | - |
| 259 | DNA | Ginkgo Bioworks Holdings, Inc. | 371.36M | -3.48% | 544,428 | 170.16M |
| 260 | BCYC | Bicycle Therapeutics plc | 371.12M | -0.56% | 375,772 | 28.34M |
| 261 | IMRX | Immuneering Corporation | 367.23M | 1.07% | 466,619 | - |
| 262 | NGNE | Neurogene Inc. | 355.03M | -2.88% | 73,890 | 925.00K |
| 263 | AURA | Aura Biosciences, Inc. | 354.35M | -1.59% | 285,077 | - |
| 264 | CLYM | Climb Bio, Inc. | 350.14M | 1.10% | 553,868 | - |
| 265 | IRD | Opus Genetics, Inc. | 344.82M | 4.82% | 1,195,128 | 14.20M |
| 266 | NERV | Minerva Neurosciences, Inc. | 343.60M | -0.75% | 314,515 | - |
| 267 | RZLT | Rezolute, Inc. | 337.58M | -0.31% | 986,806 | - |
| 268 | ANL | Adlai Nortye Ltd. | 329.15M | 1.48% | 135,956 | -1.35M |
| 269 | XOMA | XOMA Royalty Corporation | 327.77M | 0.44% | 130,475 | 47.11M |
| 270 | CABA | Cabaletta Bio, Inc. | 321.53M | 2.14% | 1,728,021 | - |
| 271 | FHTX | Foghorn Therapeutics Inc. | 319.56M | -0.46% | 186,067 | 24.52M |
| 272 | AVTX | Avalo Therapeutics, Inc. | 313.42M | -2.20% | 533,169 | 192.00K |
| 273 | NAUT | Nautilus Biotechnology, Inc. | 312.61M | -1.59% | 139,034 | - |
| 274 | PBYI | Puma Biotechnology, Inc. | 309.33M | -2.25% | 287,379 | 228.37M |
| 275 | CAMP | Camp4 Therapeutics Corporation | 307.36M | -5.66% | 400,885 | 3.50M |
| 276 | CCCC | C4 Therapeutics, Inc. | 306.40M | -12.53% | 2,986,158 | 35.95M |
| 277 | ALDX | Aldeyra Therapeutics, Inc. | 305.13M | -3.61% | 1,252,473 | - |
| 278 | TARA | Protara Therapeutics, Inc. | 304.91M | -1.04% | 750,937 | - |
| 279 | ACIU | AC Immune SA | 299.80M | 5.94% | 259,143 | 5.48M |
| 280 | SLN | Silence Therapeutics plc | 293.80M | 0.48% | 253,964 | 559.00K |
| 281 | PRLD | Prelude Therapeutics Incorporated | 291.69M | 14.56% | 354,135 | 12.14M |
| 282 | VYGR | Voyager Therapeutics, Inc. | 291.44M | 18.98% | 4,569,220 | 40.37M |
| 283 | CHRS | Coherus Oncology, Inc. | 289.29M | - | 2,221,028 | 42.17M |
| 284 | HELP | Cybin Inc. | 288.71M | 4.53% | 802,630 | - |
| 285 | PALI | Palisade Bio, Inc. | 286.09M | 10.34% | 4,086,100 | - |
| 286 | OVID | Ovid Therapeutics Inc. | 285.10M | 2.34% | 3,023,382 | 6.61M |
| 287 | OABI | OmniAb, Inc. | 280.15M | -0.77% | 233,654 | 18.67M |
| 288 | ABEO | Abeona Therapeutics Inc. | 278.54M | -0.39% | 1,707,986 | 400.00K |
| 289 | ENLV | Enlivex Ltd. | 275.36M | - | 107,781 | - |
| 290 | PLYX | Polaryx Therapeutics, Inc. | 275.06M | 65.06% | 22,121,432 | - |
| 291 | CLLS | Cellectis S.A. | 273.34M | 6.94% | 34,650 | 82.55M |
| 292 | ALEC | Alector, Inc. | 270.39M | 11.87% | 1,560,207 | 21.05M |
| 293 | FENC | Fennec Pharmaceuticals Inc. | 270.15M | 4.22% | 77,666 | 38.79M |
| 294 | CBUS | Cibus, Inc. | 269.54M | 8.42% | 521,220 | 3.79M |
| 295 | CNTX | Context Therapeutics Inc. | 269.21M | 1.03% | 685,087 | - |
| 296 | ALXO | ALX Oncology Holdings Inc. | 267.64M | -4.23% | 360,488 | - |
| 297 | SRZN | Surrozen, Inc. | 265.23M | 3.83% | 79,812 | 3.60M |
| 298 | IKT | Inhibikase Therapeutics, Inc. | 264.67M | 2.38% | 1,515,154 | 1.00 |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 262.56M | -0.43% | 133,595 | 2.82M |
| 300 | NVCT | Nuvectis Pharma, Inc. | 255.64M | 6.28% | 74,624 | - |
| 301 | EDIT | Editas Medicine, Inc. | 253.49M | 11.64% | 3,775,176 | 40.52M |
| 302 | CNTN | Canton Strategic Holdings, Inc. | 242.14M | 5.62% | 442,710 | - |
| 303 | SLGL | Sol-Gel Technologies Ltd. | 241.11M | 1.84% | 14,988 | 18.97M |
| 304 | HUMA | Humacyte, Inc. | 239.32M | 3.33% | 5,665,468 | 1.57M |
| 305 | PLX | Protalix BioTherapeutics, Inc. | 234.03M | 1.04% | 510,720 | 61.84M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 232.11M | 0.86% | 1,585,065 | - |
| 307 | ELTX | Elicio Therapeutics, Inc. | 230.15M | 11.80% | 222,025 | - |
| 308 | RNAC | Cartesian Therapeutics, Inc. | 226.39M | -5.32% | 344,013 | 2.80M |
| 309 | ACHV | Achieve Life Sciences, Inc. | 226.24M | 0.71% | 268,843 | - |
| 310 | KROS | Keros Therapeutics, Inc. | 225.67M | 0.84% | 468,423 | 244.06M |
| 311 | MDWD | MediWound Ltd. | 221.97M | -1.20% | 54,224 | 16.96M |
| 312 | ARCT | Arcturus Therapeutics Holdings Inc. | 216.30M | 3.40% | 363,344 | 82.03M |
| 313 | MGNX | MacroGenics, Inc. | 211.64M | 41.10% | 12,356,510 | 149.50M |
| 314 | CGEN | Compugen Ltd. | 208.96M | 2.79% | 308,748 | 72.76M |
| 315 | ABOS | Acumen Pharmaceuticals, Inc. | 207.17M | 8.92% | 315,359 | - |
| 316 | GALT | Galectin Therapeutics Inc. | 199.54M | -7.61% | 598,764 | - |
| 317 | ZNTL | Zentalis Pharmaceuticals, Inc. | 197.49M | 22.98% | 1,788,941 | 26.87M |
| 318 | PMN | ProMIS Neurosciences, Inc. | 195.00M | -8.52% | 33,283 | - |
| 319 | TNYA | Tenaya Therapeutics, Inc. | 194.57M | -6.15% | 6,800,732 | - |
| 320 | CRBU | Caribou Biosciences, Inc. | 194.24M | 2.03% | 2,008,329 | 11.16M |
| 321 | SABS | SAB Biotherapeutics, Inc. | 193.28M | 5.73% | 1,322,971 | 114.70K |
| 322 | WHWK | Whitehawk Therapeutics, Inc. | 193.23M | 0.49% | 177,350 | 14.38M |
| 323 | NTHI | NeOnc Technologies Holdings, Inc. | 189.83M | -1.85% | 22,589 | 59.99K |
| 324 | PRQR | ProQR Therapeutics N.V. | 189.09M | -5.03% | 277,895 | 18.86M |
| 325 | HRTX | Heron Therapeutics, Inc. | 186.65M | -0.65% | 997,346 | 154.90M |
| 326 | VXRT | Vaxart, Inc. | 185.71M | -3.27% | 311,837 | 148.20M |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 183.71M | 3.82% | 275,740 | - |
| 328 | NKTX | Nkarta, Inc. | 183.26M | - | 588,048 | - |
| 329 | MENS | Jyong Biotech Ltd. | 181.48M | 0.43% | 64,459 | - |
| 330 | TNXP | Tonix Pharmaceuticals Holding Corp. | 179.69M | 0.75% | 231,428 | 10.30M |
| 331 | SGMT | Sagimet Biosciences Inc. | 179.52M | 2.60% | 174,980 | - |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 178.78M | 5.39% | 1,154,557 | - |
| 333 | KLRS | Kalaris Therapeutics, Inc. | 177.77M | -4.95% | 21,481 | - |
| 334 | TLSA | Tiziana Life Sciences Ltd | 176.12M | - | 33,815 | - |
| 335 | MOLN | Molecular Partners AG | 175.48M | 1.02% | 2,812 | 856.30K |
| 336 | IMUX | Immunic, Inc. | 170.70M | 4.67% | 3,858,380 | - |
| 337 | RANI | Rani Therapeutics Holdings, Inc. | 164.66M | -1.81% | 930,975 | 1.20M |
| 338 | CNTB | Connect Biopharma Holdings Limited | 158.77M | 7.17% | 173,755 | 762.00K |
| 339 | ADAG | Adagene Inc. | 155.06M | 7.87% | 63,512 | 103.20K |
| 340 | SGMO | Sangamo Therapeutics, Inc. | 153.47M | 0.66% | 2,207,929 | 32.88M |
| 341 | FATE | Fate Therapeutics, Inc. | 153.47M | -0.75% | 904,505 | 6.65M |
| 342 | KPTI | Karyopharm Therapeutics Inc. | 152.44M | -2.12% | 498,042 | 146.07M |
| 343 | IPHA | Innate Pharma S.A. | 149.94M | 0.94% | 15,248 | 14.84M |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 149.37M | -1.42% | 391,573 | - |
| 345 | ARTV | Artiva Biotherapeutics, Inc. | 147.02M | 4.90% | 130,934 | 251.00K |
| 346 | ANTX | AN2 Therapeutics, Inc. | 144.00M | 0.10% | 3,708,437 | - |
| 347 | SPRO | Spero Therapeutics, Inc. | 138.03M | 5.60% | 430,851 | 40.55M |
| 348 | CRDF | Cardiff Oncology, Inc. | 136.05M | - | 425,350 | 593.00K |
| 349 | ORMP | Oramed Pharmaceuticals Inc. | 132.74M | 2.30% | 124,224 | 2.00M |
| 350 | DTIL | Precision BioSciences, Inc. | 129.99M | 14.65% | 353,091 | 698.00K |
| 351 | ACOG | Alpha Cognition Inc. | 128.28M | 0.51% | 12,080 | 7.43M |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 127.34M | 2.52% | 684,791 | 70.00M |
| 353 | AARD | Aardvark Therapeutics, Inc. | 126.28M | -4.76% | 502,220 | - |
| 354 | GNLX | Genelux Corporation | 125.33M | - | 64,715 | 8.00K |
| 355 | EQ | Equillium, Inc. | 120.57M | -1.98% | 195,817 | 4.39M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 119.54M | 0.58% | 417,063 | 182.34K |
| 357 | GOSS | Gossamer Bio, Inc. | 117.14M | -8.86% | 7,709,853 | 44.05M |
| 358 | AGEN | Agenus Inc. | 115.97M | 8.25% | 729,557 | 106.83M |
| 359 | COYA | Coya Therapeutics, Inc. | 115.13M | 1.45% | 115,308 | 3.99M |
| 360 | KRRO | Korro Bio, Inc. | 114.98M | -5.77% | 142,870 | 7.37M |
| 361 | SAVA | Cassava Sciences, Inc. | 114.49M | 11.79% | 1,875,112 | - |
| 362 | DWTX | Dogwood Therapeutics, Inc. | 112.54M | 10.46% | 78,639 | - |
| 363 | CDXS | Codexis, Inc. | 112.00M | -0.80% | 616,146 | 52.93M |
| 364 | ONCY | Oncolytics Biotech Inc. | 110.30M | -3.30% | 760,942 | - |
| 365 | GANX | Gain Therapeutics, Inc. | 106.92M | -5.12% | 642,234 | - |
| 366 | HURA | TuHURA Biosciences, Inc. | 106.26M | 3.55% | 502,269 | - |
| 367 | BMEA | Biomea Fusion, Inc. | 103.93M | 3.52% | 1,552,330 | - |
| 368 | FBIO | Fortress Biotech, Inc. | 103.36M | -1.19% | 208,410 | 62.30M |
| 369 | TTRX | Turn Therapeutics Inc. | 102.76M | 0.58% | 3,090 | - |
| 370 | SEER | Seer, Inc. | 99.58M | -2.49% | 1,052,917 | 16.58M |
| 371 | ANIX | Anixa Biosciences, Inc. | 99.14M | -0.34% | 63,480 | - |
| 372 | CGTX | Cognition Therapeutics, Inc. | 98.88M | 3.71% | 790,292 | - |
| 373 | PYXS | Pyxis Oncology, Inc. | 96.51M | 3.33% | 584,814 | 2.82M |
| 374 | VRCA | Verrica Pharmaceuticals Inc. | 94.66M | 4.23% | 226,087 | 30.83M |
| 375 | VANI | Vivani Medical, Inc. | 94.23M | 0.85% | 92,125 | - |
| 376 | ATYR | aTyr Pharma, Inc. | 91.98M | 4.28% | 983,775 | 190.00K |
| 377 | KZIA | Kazia Therapeutics Limited | 91.64M | 2.31% | 61,104 | 1.20M |
| 378 | SPRB | Spruce Biosciences, Inc. | 88.98M | 4.41% | 69,137 | 697.00K |
| 379 | MAIA | MAIA Biotechnology, Inc. | 88.58M | 1.34% | 1,143,796 | - |
| 380 | PMVP | PMV Pharmaceuticals, Inc. | 87.99M | 1.23% | 502,874 | - |
| 381 | OKYO | OKYO Pharma Limited | 86.30M | -1.75% | 48,508 | - |
| 382 | PLRX | Pliant Therapeutics, Inc. | 85.72M | 5.68% | 513,599 | - |
| 383 | QTTB | Q32 Bio Inc. | 84.11M | 18.04% | 395,823 | 53.74M |
| 384 | IBIO | iBio, Inc. | 83.25M | -3.60% | 528,157 | 300.00K |
| 385 | PYPD | PolyPid Ltd. | 82.25M | 3.11% | 40,973 | - |
| 386 | CING | Cingulate Inc. | 81.78M | 14.60% | 428,749 | - |
| 387 | MCRB | Seres Therapeutics, Inc. | 80.69M | -4.29% | 40,475 | 351.00K |
| 388 | CSBR | Champions Oncology, Inc. | 80.61M | -2.76% | 14,124 | 58.42M |
| 389 | PTHS | Pelthos Therapeutics Inc. | 79.27M | 6.29% | 967 | 7.41M |
| 390 | ACET | Adicet Bio, Inc. | 77.01M | 0.13% | 134,712 | - |
| 391 | GUTS | Fractyl Health, Inc. | 74.48M | -0.70% | 1,431,132 | 3.00K |
| 392 | COEP | Coeptis Therapeutics Holdings, Inc. | 72.71M | 0.55% | 36,907 | 501.00K |
| 393 | XBIT | XBiotech Inc. | 71.65M | - | 8,518 | - |
| 394 | MNOV | MediciNova, Inc. | 69.40M | 2.17% | 11,411 | 409.66K |
| 395 | ANVS | Annovis Bio, Inc. | 68.91M | 1.17% | 190,602 | - |
| 396 | ENTX | Entera Bio Ltd. | 67.41M | 10.53% | 76,476 | 124.00K |
| 397 | TCRX | TScan Therapeutics, Inc. | 67.14M | -4.84% | 453,072 | 10.33M |
| 398 | NRXS | NeurAxis, Inc. | 66.05M | 7.83% | 182,861 | 3.36M |
| 399 | MGX | Metagenomi Therapeutics, Inc. | 65.84M | 9.37% | 701,643 | 25.21M |
| 400 | ACTU | Actuate Therapeutics, Inc. | 65.43M | -4.41% | 40,961 | - |
| 401 | IMA | ImageneBio, Inc. | 64.23M | 1.86% | 41,573 | 800.00K |
| 402 | IFRX | InflaRx N.V. | 64.01M | -0.66% | 230,587 | 73.73K |
| 403 | INKT | MiNK Therapeutics, Inc. | 62.81M | 28.04% | 15,369,413 | - |
| 404 | MREO | Mereo BioPharma Group plc | 62.49M | 0.28% | 762,494 | 500.00K |
| 405 | EXOZ | eXoZymes, Inc. | 61.99M | 0.27% | 2,953 | -700.00 |
| 406 | LONA | LeonaBio, Inc. | 61.52M | 6.81% | 54,845 | - |
| 407 | TIL | Instil Bio, Inc. | 61.44M | 1.80% | 18,592 | - |
| 408 | IBO | Impact BioMedical Inc. | 61.34M | -8.23% | 332,572 | 25.00K |
| 409 | GRCE | Grace Therapeutics, Inc. | 61.12M | 0.51% | 243,284 | - |
| 410 | HYFT | MindWalk Holdings Corp. | 60.70M | 18.18% | 872,244 | 19.02M |
| 411 | BYSI | BeyondSpring Inc. | 59.63M | -2.03% | 5,959 | 1.88M |
| 412 | ICCC | ImmuCell Corporation | 59.16M | 0.93% | 10,403 | 27.64M |
| 413 | EDSA | Edesa Biotech, Inc. | 57.18M | -4.06% | 1,620,742 | - |
| 414 | OSTX | OS Therapies Incorporated | 57.05M | -5.26% | 1,262,213 | - |
| 415 | NRXP | NRx Pharmaceuticals, Inc. | 56.57M | 2.60% | 652,975 | 242.00K |
| 416 | RADX | Radiopharm Theranostics Limited | 54.96M | 1.82% | 39,081 | 10.86M |
| 417 | KLTO | Klotho Neurosciences, Inc. | 54.73M | 7.47% | 4,348,482 | - |
| 418 | ESLA | Estrella Immunopharma, Inc. | 54.64M | 16.07% | 93,412 | - |
| 419 | ATHE | Alterity Therapeutics Limited | 53.66M | 1.41% | 8,444 | 4.43M |
| 420 | PSTV | Plus Therapeutics, Inc. | 52.91M | 1.32% | 2,343,918 | 5.26M |
| 421 | KZR | Kezar Life Sciences, Inc. | 52.76M | 2.93% | 19,441 | - |
| 422 | ACRV | Acrivon Therapeutics, Inc. | 52.70M | 4.37% | 442,595 | - |
| 423 | RLYB | Rallybio Corporation | 51.89M | -8.87% | 85,547 | 674.00K |
| 424 | NTRB | Nutriband Inc. | 49.38M | -4.41% | 21,280 | 2.28M |
| 425 | OKUR | OnKure Therapeutics, Inc. | 48.10M | 4.41% | 191,562 | - |
| 426 | LPCN | Lipocine Inc. | 45.41M | 3.81% | 117,838 | 1.98M |
| 427 | NXTC | NextCure, Inc. | 45.22M | 1.52% | 32,630 | - |
| 428 | ALGS | Aligos Therapeutics, Inc. | 44.80M | 3.06% | 29,060 | 2.19M |
| 429 | CRVO | CervoMed Inc. | 44.60M | 6.17% | 144,918 | 6.16M |
| 430 | ATRA | Atara Biotherapeutics, Inc. | 44.49M | -7.63% | 523,998 | 151.93M |
| 431 | LSTA | Lisata Therapeutics, Inc. | 44.42M | -0.09% | 47,842 | 1.07M |
| 432 | APLM | Apollomics, Inc. | 43.78M | 1.95% | 879 | 6.93M |
| 433 | LITS | Lite Strategy, Inc. | 43.09M | -1.25% | 277,368 | - |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 42.98M | -6.01% | 95,555 | - |
| 435 | XLO | Xilio Therapeutics, Inc. | 41.19M | 3.83% | 355,532 | 31.80M |
| 436 | ATOS | Atossa Therapeutics, Inc. | 40.82M | 3.72% | 105,504 | - |
| 437 | PTN | Palatin Technologies, Inc. | 39.98M | -3.31% | 18,588 | 8.96M |
| 438 | VERU | Veru Inc. | 39.64M | 0.41% | 44,433 | 16.89M |
| 439 | SNSE | Sensei Biotherapeutics, Inc. | 38.75M | 3.81% | 70,659 | - |
| 440 | JSPR | Jasper Therapeutics, Inc. | 38.62M | 5.34% | 378,331 | - |
| 441 | CELU | Celularity Inc. | 38.35M | 6.40% | 6,693,902 | 40.58M |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 37.44M | - | 26,655 | 90.00K |
| 443 | OTLK | Outlook Therapeutics, Inc. | 36.96M | -0.58% | 651,831 | 205.70K |
| 444 | PDSB | PDS Biotechnology Corporation | 36.80M | -1.84% | 151,550 | - |
| 445 | TVRD | Tvardi Therapeutics, Inc. | 36.21M | -3.02% | 20,466 | - |
| 446 | ABVC | ABVC BioPharma, Inc. | 36.08M | - | 40,913 | 797.92K |
| 447 | HOWL | Werewolf Therapeutics, Inc. | 35.41M | -0.45% | 213,072 | 1.14M |
| 448 | PLUR | Pluri Inc. | 34.37M | 1.48% | 5,840 | 1.34M |
| 449 | INMB | INmune Bio Inc. | 34.29M | -1.53% | 218,077 | 50.00K |
| 450 | NBY | NovaBay Pharmaceuticals, Inc. | 33.05M | 2.02% | 297,858 | 10.30M |
| 451 | TPST | Tempest Therapeutics, Inc. | 32.08M | -0.42% | 77,106 | - |
| 452 | RNTX | Rein Therapeutics Inc. | 31.94M | 1.25% | 87,391 | - |
| 453 | LTRN | Lantern Pharma Inc. | 30.70M | 0.18% | 15,900 | - |
| 454 | CUE | Cue Biopharma, Inc. | 30.41M | 3.65% | 1,468,432 | 7.10M |
| 455 | RNXT | RenovoRx, Inc. | 30.31M | 3.35% | 164,309 | 928.00K |
| 456 | EVAX | Evaxion A/S | 30.27M | 17.86% | 47,232 | 7.53M |
| 457 | CVM | CEL-SCI Corporation | 30.27M | -3.36% | 14,777 | - |
| 458 | TVGN | Tevogen Bio Holdings Inc. | 29.76M | -5.16% | 24,879 | - |
| 459 | DYAI | Dyadic International, Inc. | 29.70M | 2.57% | 57,775 | 3.34M |
| 460 | KYNB | Kyntra Bio, Inc. | 29.21M | -1.63% | 11,131 | 8.30M |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 28.76M | 2.49% | 169,705 | - |
| 462 | AEON | AEON Biopharma, Inc. | 28.59M | 5.61% | 31,912 | - |
| 463 | PASG | Passage Bio, Inc. | 27.72M | -1.71% | 19,842 | - |
| 464 | HYPD | Hyperion DeFi, Inc. | 27.29M | -4.41% | 161,880 | 345.32K |
| 465 | BCTX | BriaCell Therapeutics Corp. | 27.09M | 1.86% | 145,998 | - |
| 466 | IGC | IGC Pharma, Inc. | 27.02M | -2.69% | 168,545 | 1.11M |
| 467 | FBLG | FibroBiologics, Inc. | 26.81M | -0.90% | 776,817 | - |
| 468 | SNTI | Senti Biosciences, Inc. | 25.98M | 1.59% | 87,197 | - |
| 469 | BOLD | Boundless Bio, Inc. | 25.85M | 1.32% | 71,659 | - |
| 470 | BRNS | Barinthus Biotherapeutics plc | 25.23M | 9.94% | 1,819 | 14.97M |
| 471 | SKYE | Skye Bioscience, Inc. | 25.22M | 8.67% | 16,270,999 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 25.05M | 2.37% | 59,123 | 14.99M |
| 473 | XCUR | Exicure, Inc. | 24.79M | -4.89% | 16,164 | 500.00K |
| 474 | MRKR | Marker Therapeutics, Inc. | 24.68M | 0.68% | 92,721 | 4.69M |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 24.47M | 0.42% | 269,068 | 789.00K |
| 476 | LIXT | Lixte Biotechnology Holdings, Inc. | 22.39M | 2.39% | 20,504 | - |
| 477 | DARE | Daré Bioscience, Inc. | 21.58M | -1.31% | 21,048 | -57.13K |
| 478 | CTXR | Citius Pharmaceuticals, Inc. | 20.61M | 9.76% | 1,707,283 | 3.94M |
| 479 | NNVC | NanoViricides, Inc. | 20.53M | -2.99% | 61,256 | - |
| 480 | PLRZ | Polyrizon Ltd. | 20.42M | -1.31% | 11,080 | - |
| 481 | VYNE | VYNE Therapeutics Inc. | 20.16M | 2.49% | 106,654 | 570.00K |
| 482 | ALLR | Allarity Therapeutics, Inc. | 20.02M | 0.40% | 160,084 | - |
| 483 | INTS | Intensity Therapeutics, Inc. | 19.74M | 0.26% | 17,062 | - |
| 484 | GNTA | Genenta Science S.p.A. | 19.73M | -1.80% | 36,552 | - |
| 485 | LGVN | Longeveron Inc. | 19.41M | 71.84% | 242,574,214 | 1.44M |
| 486 | IOBT | IO Biotech, Inc. | 19.07M | -5.32% | 1,412,864 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 18.97M | 2.70% | 55,653 | - |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 18.75M | 0.25% | 31,955 | - |
| 489 | LEXX | Lexaria Bioscience Corp. | 18.47M | 1.73% | 55,727 | 522.00K |
| 490 | INAB | IN8bio, Inc. | 18.26M | 5.65% | 45,409 | - |
| 491 | SER | Serina Therapeutics, Inc. | 17.26M | 0.63% | 28,698 | 116.00K |
| 492 | HOTH | Hoth Therapeutics, Inc. | 15.65M | 1.86% | 376,399 | - |
| 493 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 15.54M | -7.64% | 385,691 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 14.73M | 3.77% | 53,399 | - |
| 495 | TRAW | Traws Pharma, Inc. | 14.46M | 8.38% | 81,825 | 2.85M |
| 496 | JUNS | Jupiter Neurosciences, Inc. | 14.39M | -1.46% | 392,236 | - |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 14.29M | 1.65% | 275,490 | - |
| 498 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.23M | 0.24% | 5,207 | - |
| 499 | CRIS | Curis, Inc. | 13.97M | -0.97% | 77,550 | 11.65M |
| 500 | BCDA | BioCardia, Inc. | 13.69M | 0.78% | 32,050 | 3.00K |
| 501 | GTBP | GT Biopharma, Inc. | 13.44M | 2.11% | 500,952 | - |
| 502 | KAPA | Kairos Pharma, Ltd. | 13.29M | 1.17% | 128,932 | - |
| 503 | CLRB | Cellectar Biosciences, Inc. | 13.10M | 12.36% | 142,480 | - |
| 504 | BCAB | BioAtla, Inc. | 12.95M | -7.77% | 1,088,266 | 11.00M |
| 505 | QNTM | Quantum BioPharma Ltd. | 12.94M | -9.23% | 171,056 | - |
| 506 | NCEL | NewcelX Ltd. | 12.76M | 2.19% | 41,960 | - |
| 507 | OSRH | OSR Holdings, Inc. | 12.47M | -3.19% | 225,570 | -90.52K |
| 508 | SNGX | Soligenix, Inc. | 12.31M | 1.67% | 309,963 | 2.34K |
| 509 | CMMB | Chemomab Therapeutics Ltd. | 12.00M | -2.50% | 107,318 | - |
| 510 | AKTX | Akari Therapeutics, Plc | 11.97M | 5.25% | 749,352 | - |
| 511 | GDTC | CytoMed Therapeutics Limited | 11.87M | -2.99% | 1,507 | 573.19K |
| 512 | BLRX | BioLineRx Ltd. | 11.78M | 1.14% | 5,021 | 12.74M |
| 513 | PHGE | BiomX Inc. | 11.54M | -2.43% | 78,374 | - |
| 514 | LIMN | Liminatus Pharma, Inc. | 10.77M | 2.78% | 999,051 | - |
| 515 | CALC | CalciMedica, Inc. | 10.67M | -7.33% | 224,084 | - |
| 516 | IMNN | Imunon, Inc. | 10.61M | - | 14,978 | - |
| 517 | BIVI | BioVie Inc. | 10.18M | -2.88% | 70,026 | - |
| 518 | MBRX | Moleculin Biotech, Inc. | 9.77M | 1.02% | 93,720 | - |
| 519 | ICU | SeaStar Medical Holding Corporation | 9.73M | 2.27% | 39,831 | 881.00K |
| 520 | ITRM | Iterum Therapeutics plc | 9.49M | 0.45% | 937,020 | 390.00K |
| 521 | CDIO | Cardio Diagnostics Holdings, Inc. | 9.02M | 1.65% | 300,700 | 15.78K |
| 522 | CLGN | CollPlant Biotechnologies Ltd. | 8.99M | -0.87% | 26,481 | 2.48M |
| 523 | RNAZ | TransCode Therapeutics, Inc. | 8.93M | 0.72% | 2,886 | - |
| 524 | KALA | KALA BIO, Inc. | 8.84M | 20.19% | 1,007,377 | - |
| 525 | ERNA | Ernexa Therapeutics Inc. | 8.79M | 14.65% | 4,668,050 | 1,000.00 |
| 526 | NCNA | NuCana plc | 8.53M | 5.13% | 22,595 | - |
| 527 | BOLT | Bolt Biotherapeutics, Inc. | 8.31M | 5.10% | 2,209 | 5.20M |
| 528 | TOVX | Theriva Biologics, Inc. | 8.23M | -1.97% | 749,015 | - |
| 529 | ALZN | Alzamend Neuro, Inc. | 8.16M | 2.10% | 67,805 | - |
| 530 | TCRT | Alaunos Therapeutics, Inc. | 7.99M | -1.92% | 6,913 | 6.00K |
| 531 | KPRX | Kiora Pharmaceuticals, Inc. | 7.85M | - | 24,484 | 20.00K |
| 532 | GRDX | GridAI Technologies Corp. | 7.83M | 9.39% | 122,350 | - |
| 533 | PMCB | PharmaCyte Biotech, Inc. | 7.69M | 2.27% | 57,938 | - |
| 534 | PULM | Pulmatrix, Inc. | 7.67M | 2.44% | 25,164 | 3.00K |
| 535 | MLEC | Moolec Science SA | 7.47M | 14.72% | 172,425 | 7.83M |
| 536 | IMRN | Immuron Limited | 7.37M | 4.40% | 2,559 | 4.99M |
| 537 | MBIO | Mustang Bio, Inc. | 7.23M | 7.71% | 67,299 | - |
| 538 | ACXP | Acurx Pharmaceuticals, Inc. | 7.13M | 43.22% | 30,597,337 | - |
| 539 | CELZ | Creative Medical Technology Holdings, Inc. | 6.85M | 2.62% | 5,928 | 6.00K |
| 540 | ADXN | Addex Therapeutics Ltd | 6.73M | -2.08% | 513 | 198.82K |
| 541 | XTLB | XTL Biopharmaceuticals Ltd. | 6.71M | -10.11% | 88,643 | 968.00K |
| 542 | EVGN | Evogene Ltd. | 6.67M | -0.31% | 43,300 | 3.85M |
| 543 | APM | Aptorum Group Limited | 6.61M | 1.51% | 23,333 | - |
| 544 | PCSA | Processa Pharmaceuticals, Inc. | 6.50M | 2.47% | 11,009 | - |
| 545 | ASBP | Aspire Biopharma Holdings, Inc. | 6.33M | 5.00% | 212,674 | 1.94K |
| 546 | PPBT | Purple Biotech Ltd | 6.02M | -7.05% | 17,508 | - |
| 547 | XBIO | Xenetic Biosciences, Inc. | 5.98M | 12.99% | 104,920 | 2.86M |
| 548 | BRTX | BioRestorative Therapies, Inc. | 5.95M | 19.66% | 156,146,068 | 383.40K |
| 549 | APRE | Aprea Therapeutics, Inc. | 5.92M | 0.22% | 73,811 | 488.24K |
| 550 | SLXN | Silexion Therapeutics Corp | 5.88M | -4.13% | 31,749 | - |
| 551 | PBM | Psyence Biomedical Ltd. | 5.77M | -1.35% | 28,523 | - |
| 552 | CYCN | Cyclerion Therapeutics, Inc. | 5.69M | 0.34% | 67,695 | 2.86M |
| 553 | QNCX | Quince Therapeutics, Inc. | 5.58M | -5.82% | 15,837,596 | - |
| 554 | CANF | Can-Fite BioPharma Ltd. | 5.58M | 2.94% | 72,930 | 560.00K |
| 555 | APVO | Aptevo Therapeutics Inc. | 5.19M | -22.79% | 875,424 | - |
| 556 | MTVA | MetaVia Inc. | 5.07M | 9.72% | 91,293 | - |
| 557 | GOVX | GeoVax Labs, Inc. | 5.07M | 0.52% | 66,311 | 3.35M |
| 558 | VIVS | VivoSim Labs, Inc. | 5.01M | 2.67% | 16,982 | 142.00K |
| 559 | REVB | Revelation Biosciences, Inc. | 4.89M | 2.73% | 90,073 | - |
| 560 | GNPX | Genprex, Inc. | 4.65M | 1.26% | 415,324 | - |
| 561 | BGMS | Bio Green Med Solution, Inc. | 4.61M | 0.53% | 19,840 | 81.00K |
| 562 | DCOY | Decoy Therapeutics Inc. | 4.59M | 0.11% | 24,976 | - |
| 563 | LNAI | Lunai Bioworks Inc. | 4.57M | -14.18% | 460,677 | - |
| 564 | SILO | Silo Pharma, Inc. | 4.42M | -2.61% | 94,874 | 72.10K |
| 565 | OGEN | Oragenics, Inc. | 4.23M | 3.25% | 255,608 | - |
| 566 | INDP | Indaptus Therapeutics, Inc. | 4.10M | -2.13% | 26,343 | - |
| 567 | MTNB | Matinas BioPharma Holdings, Inc. | 4.04M | 4.36% | 12,717 | - |
| 568 | GLMD | Galmed Pharmaceuticals Ltd. | 4.02M | -0.83% | 6,008 | - |
| 569 | GRI | GRI Bio, Inc. | 3.93M | 8.80% | 70,483 | - |
| 570 | AZTR | Azitra, Inc. | 3.34M | 1.72% | 1,412,358 | 7.50K |
| 571 | HCWB | HCW Biologics Inc. | 3.31M | -2.83% | 78,434 | 422.03K |
| 572 | DRMA | Dermata Therapeutics, Inc. | 3.15M | -0.75% | 82,714 | - |
| 573 | XRTX | XORTX Therapeutics Inc. | 3.07M | -4.33% | 15,752 | - |
| 574 | CDT | CDT Equity Inc. | 2.87M | -5.13% | 28,232 | - |
| 575 | ARTL | Artelo Biosciences, Inc. | 2.86M | 15.10% | 108,834 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 2.79M | 1.01% | 45,626 | - |
| 577 | CLDI | Calidi Biotherapeutics, Inc. | 2.66M | -1.37% | 436,112 | - |
| 578 | ADIL | Adial Pharmaceuticals, Inc. | 2.57M | 4.65% | 46,530 | - |
| 579 | SCNI | Scinai Immunotherapeutics Ltd. | 2.54M | -1.21% | 4,739 | 1.15M |
| 580 | ELAB | PMGC Holdings Inc. | 2.53M | 9.05% | 359,323 | 285.95K |
| 581 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.43M | -2.07% | 54,401 | 1.36M |
| 582 | LYRA | Lyra Therapeutics, Inc. | 2.31M | -0.01% | 12,758 | 600.00K |
| 583 | BBLG | Bone Biologics Corporation | 2.28M | 4.10% | 13,947 | - |
| 584 | SPRC | SciSparc Ltd. | 2.21M | -30.30% | 978,506 | 1.31M |
| 585 | PPCB | Propanc Biopharma, Inc. | 2.15M | -21.16% | 4,576,729 | - |
| 586 | JAGX | Jaguar Health, Inc. | 2.13M | -4.54% | 599,153 | 11.79M |
| 587 | CNSP | CNS Pharmaceuticals, Inc. | 2.01M | 7.28% | 12,058 | - |
| 588 | ENSC | Ensysce Biosciences, Inc. | 1.80M | -7.99% | 424,055 | 4.49M |
| 589 | CMND | Clearmind Medicine Inc. | 1.79M | -1.96% | 308,742 | - |
| 590 | VRAX | Virax Biolabs Group Limited | 1.50M | 1.10% | 43,333 | 2.99K |
| 591 | ONCO | Onconetix, Inc. | 849.04K | 3.61% | 89,134 | 1.22M |
| 592 | BDRX | Biodexa Pharmaceuticals Plc | 796.68K | -0.02% | 49,221 | 104.90K |
| 593 | ADTX | Aditxt, Inc. | 614.95K | -20.17% | 151,393 | 5.95K |